How to take Pomalidomide

The recommended dose of pomalidomide for the treatment of multiple myeloma (MM) is 4 mg once daily on days 1-21 of each 28-day cycle until disease progression or unacceptable toxicity, when combined with dexamethasone. The recommended dose of pomalidomide for the treatment of Kaposi's sarcoma (KS) is 5 mg once daily on days 1-21 of each 28-day cycle, with continuation of antiretroviral therapy as HIV treatment in patients with AIDS-associated Kaposi's sarcoma.

If adverse reactions occur after using pomalidomide, the dose should be adjusted, and if 1 mg once daily is not tolerated, pomalidomide should be permanently discontinued. Women of childbearing potential must have a negative pregnancy test and use birth control before starting pomalidomide. Pomalidomide is a thalidomide analogue that is teratogenic in rats and rabbits when administered during organogenesis. If a patient becomes pregnant while taking this drug, it may cause harm to the fetus.

Pomalidomide, independently developed in China, has been launched domestically and has now entered the scope of medical insurance. The price of domestically produced Pomalidomide may be around RMB 4,000 per box, while the Turkish version sold overseas may be priced around RMB 15,000 per box (the price may fluctuate due to exchange rates), which is relatively expensive. There are also cheaper generic drugs produced in other countries overseas. The price of each box produced by a Lao pharmaceutical factory may be around a few hundred yuan (the price may fluctuate due to the exchange rate). The ingredients of foreign generic drugs, domestically produced drugs and foreign original drugs are basically the same. For more drug information and specific prices, please consult Yaode Medical Consultant.